000 01375 a2200373 4500
005 20250514023736.0
264 0 _c20020306
008 200203s 0 0 eng d
022 _a1323-7799
024 7 _a10.1046/j.1440-1843.2001.00344.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAl-Hajjaj, M S
245 0 0 _aProgressive rise of Mycobacterium tuberculosis resistance to rifampicin and streptomycin in Riyadh, Saudi Arabia.
_h[electronic resource]
260 _bRespirology (Carlton, Vic.)
_cDec 2001
300 _a317-22 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntibiotics, Antitubercular
_xtherapeutic use
650 0 4 _aDrug Resistance, Multiple, Bacterial
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMycobacterium tuberculosis
_xdrug effects
650 0 4 _aRifampin
_xtherapeutic use
650 0 4 _aSaudi Arabia
_xepidemiology
650 0 4 _aStreptomycin
_xtherapeutic use
650 0 4 _aTuberculosis, Multidrug-Resistant
_xepidemiology
650 0 4 _aTuberculosis, Pulmonary
_xdrug therapy
700 1 _aAl-Kassimi, F A
700 1 _aAl-Mobeireek, A F
700 1 _aAlzeer, A H
773 0 _tRespirology (Carlton, Vic.)
_gvol. 6
_gno. 4
_gp. 317-22
856 4 0 _uhttps://doi.org/10.1046/j.1440-1843.2001.00344.x
_zAvailable from publisher's website
999 _c11752828
_d11752828